JPMorgan Chase & Co’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,134
| Closed | -$111K | – | 5324 |
|
|
2020
Q3 | $111K | Buy |
6,134
+309
| +5% | +$5.59K | ﹤0.01% | 4001 |
|
|
2020
Q2 | $80K | Buy |
5,825
+1,318
| +29% | +$18.1K | ﹤0.01% | 4046 |
|
|
2020
Q1 | $65K | Sell |
4,507
-920
| -17% | -$13.3K | ﹤0.01% | 4072 |
|
|
2019
Q4 | $91K | Sell |
5,427
-46
| -0.8% | -$771 | ﹤0.01% | 4064 |
|
|
2019
Q3 | $84K | Buy |
5,473
+662
| +14% | +$10.2K | ﹤0.01% | 4058 |
|
|
2019
Q2 | $111K | Buy |
4,811
+186
| +4% | +$4.29K | ﹤0.01% | 3982 |
|
|
2019
Q1 | $132K | Sell |
4,625
-28
| -0.6% | -$799 | ﹤0.01% | 3921 |
|
|
2018
Q4 | $140K | Buy |
4,653
+304
| +7% | +$9.15K | ﹤0.01% | 3925 |
|
|
2018
Q3 | $152K | Buy |
4,349
+31
| +0.7% | +$1.08K | ﹤0.01% | 3963 |
|
|
2018
Q2 | $102K | Sell |
4,318
-417
| -9% | -$9.85K | ﹤0.01% | 4072 |
|
|
2018
Q1 | $121K | Sell |
4,735
-3,932
| -45% | -$100K | ﹤0.01% | 3877 |
|
|
2017
Q4 | $150K | Buy |
8,667
+6,048
| +231% | +$105K | ﹤0.01% | 3766 |
|
|
2017
Q3 | $74K | Buy |
+2,619
| New | +$74K | ﹤0.01% | 3719 |
|